Downloads: 88

Files in This Item:
File Description SizeFormat 
journal.pone.0229998.pdf916.74 kBAdobe PDFView/Open
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMinamino, Hiroto
dc.contributor.authorKatsushima, Masao
dc.contributor.authorYoshida, Tamami
dc.contributor.authorHashimoto, Motomu
dc.contributor.authorFujita, Yoshihito
dc.contributor.authorShirakashi, Mirei
dc.contributor.authorYamamoto, Wataru
dc.contributor.authorMurakami, Kosaku
dc.contributor.authorMurata, Koichi
dc.contributor.authorNishitani, Kohei
dc.contributor.authorTanaka, Masao
dc.contributor.authorIto, Hiromu
dc.contributor.authorInagaki, Nobuya
dc.contributor.authorMatsuda, Shuichi
dc.contributor.alternative南野, 寛人
dc.contributor.alternative勝島, 將夫
dc.contributor.alternative吉田, 玉美
dc.contributor.alternative橋本, 求
dc.contributor.alternative藤田, 義人
dc.contributor.alternative白柏, 魅怜
dc.contributor.alternative山本, 渉
dc.contributor.alternative村上, 孝作
dc.contributor.alternative村田, 浩一
dc.contributor.alternative西谷, 江平
dc.contributor.alternative田中, 真生
dc.contributor.alternative伊藤, 宣
dc.contributor.alternative稲垣, 暢也
dc.contributor.alternative松田, 秀一
dc.description.abstractObjective: To clarify the relationship among serum adiponectin, body composition, current disease activity and therapeutics of rheumatoid arthritis (RA). Methods: We conducted a cross-sectional study in RA patients under treatment with agents including biological disease-modifying antirheumatic drugs (bDMARDs) and Janus kinase (JAK) inhibitors. A total of 351 subjects from the Kyoto University RA Management Alliance cohort (KURAMA) were enrolled in the analysis. We classified the participants into five body composition groups according to the cut-off points for obesity and visceral fat used in Japan: body mass index (BMI), 18.5 kg/m2 for underweight and 25.0 kg/m2 for obesity, and visceral fat area (VFA), 100 cm2 for visceral adiposity. Results: Classification of body composition revealed that serum adiponectin levels and disease activity score (DAS28-ESR) in the low BMI group were significantly higher than those in the normal and overweight groups. Because both increased serum adiponectin and low BMI were previously reported as poor prognostic factors of RA, we performed multiple regression analysis to determine which factor was correlated with RA disease activity. Serum adiponectin level, but not BMI, was positively associated with DAS28-ESR (estimate = 0.0127, p = 0.0258). Subanalysis also showed that the use of bDMARD or JAK inhibitor did not have an obvious influence on circulating adiponectin. Conclusions: Classification of body composition and multiple regression analysis revealed a positive and independent correlation between serum adiponectin and DAS28-ESR in Japanese RA patients. Thus, serum adiponectin may be an important marker reflecting high disease activity of RA regardless of current medications.
dc.publisherPublic Library of Science (PLoS)
dc.rights© 2020 Minamino et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.titleIncreased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database
dc.type.niitypeJournal Article
dc.identifier.jtitlePLOS ONE
Appears in Collections:Journal Articles

Show simple item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.